Literature DB >> 28497230

Heart failure with preserved ejection fraction: a nephrologist-directed primer.

Baris Afsar1, Patrick Rossignol2,3,4,5, Loek van Heerebeek6, Walter J Paulus6, Kevin Damman7, Stephane Heymans8, Vanessa van Empel8, Alan Sag9, Alan Maisel10, Mehmet Kanbay11.   

Abstract

There is substantial causal and consequential interaction between the ever-growing heart failure and renal failure patients. Half of the patients with heart failure (HF) have preserved left ventricular ejection fraction (HFpEF), which is difficult to diagnose and rising in prevalence relative to HF with reduced EF (HFpEF). To date, only weight reduction, exercise training, and diuretics have been shown to improve exercise tolerance and morbidity in HFpEF. This review aims to establish the baseline kidney-related concepts specific to the diagnosis and treatment of HFpEF patients and the different aspects of HFpEF and HFpEF in the clinical setting.

Entities:  

Keywords:  Chronic kidney disease; Heart failure; Preserved ejection fraction; Reduced ejection fraction

Mesh:

Year:  2017        PMID: 28497230     DOI: 10.1007/s10741-017-9619-2

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  93 in total

1.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

2.  Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.

Authors:  Michael R Zile; Pardeep S Jhund; Catalin F Baicu; Brian L Claggett; Burkert Pieske; Adriaan A Voors; Margaret F Prescott; Victor Shi; Martin Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

Review 3.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.

Authors:  N Glezeva; J A Baugh
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

4.  Association of anemia and renal dysfunction with in-hospital mortality among patients hospitalized for acute heart failure syndromes with preserved or reduced ejection fraction.

Authors:  Katsuya Kajimoto; Naoki Sato; Teruo Takano
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2016-09-22

Review 5.  Geographic differences in heart failure trials.

Authors:  João Pedro Ferreira; Nicolas Girerd; Patrick Rossignol; Faiez Zannad
Journal:  Eur J Heart Fail       Date:  2015-07-21       Impact factor: 15.534

6.  Cachexia as a major underestimated and unmet medical need: facts and numbers.

Authors:  Stephan von Haehling; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

7.  Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.

Authors:  Miho Kawaguchi; Ilan Hay; Barry Fetics; David A Kass
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

8.  Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.

Authors:  Neil C Henderson; Alison C Mackinnon; Sarah L Farnworth; Tiina Kipari; Christopher Haslett; John P Iredale; Fu-Tong Liu; Jeremy Hughes; Tariq Sethi
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 9.  Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.

Authors:  Jasper W L Hartog; Adriaan A Voors; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Journal:  Eur J Heart Fail       Date:  2007-12       Impact factor: 15.534

Review 10.  Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.

Authors:  Jasper W L Hartog; Andries J Smit; Willem J van Son; Gerjan Navis; Reinold O B Gans; Bruce H R Wolffenbuttel; Paul E de Jong
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

View more
  9 in total

Review 1.  Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging.

Authors:  Sadi Loai; Hai-Ling Margaret Cheng
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

Review 2.  Treatment of Disorders of Sodium Balance in Chronic Kidney Disease.

Authors:  David H Ellison
Journal:  Adv Chronic Kidney Dis       Date:  2017-09       Impact factor: 3.620

Review 3.  The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review.

Authors:  Baris Afsar; Dimitrie Siriopol; Gamze Aslan; Ozgur C Eren; Tuncay Dagel; Ugur Kilic; Asiye Kanbay; Alexandru Burlacu; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

4.  A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease.

Authors:  Mehmet Kanbay; Aslihan Yerlikaya; Alan A Sag; Alberto Ortiz; Masanari Kuwabara; Adrian Covic; Andrzej Wiecek; Peter Stenvinkel; Baris Afsar
Journal:  Clin Kidney J       Date:  2019-09-18

5.  Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve.

Authors:  Pavlos Kashioulis; Cecilia Wallentin Guron; Maria K Svensson; Ola Hammarsten; Aso Saeed; Gregor Guron
Journal:  ESC Heart Fail       Date:  2020-07-10

6.  Characteristics and complications of fracture in older adults with chronic kidney disease: a cross-sectional study.

Authors:  Yao Meng; Mingming Fu; Junfei Guo; Zhiqian Wang; Yingze Zhang; Zhiyong Hou
Journal:  J Orthop Surg Res       Date:  2022-08-06       Impact factor: 2.677

Review 7.  Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review.

Authors:  Simge Acar; Sueda Sanli; Cinar Oztosun; Baris Afsar; Alan A Sag; Masanari Kuwabara; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

Review 8.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

Review 9.  Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach.

Authors:  Antoni Bayes-Genis; Felipe Bisbal; Julio Núñez; Enrique Santas; Josep Lupón; Patrick Rossignol; Walter Paulus
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.